511 related articles for article (PubMed ID: 32088581)
21. Microbiota-based markers predictive of development of Clostridioides difficile infection.
Berkell M; Mysara M; Xavier BB; van Werkhoven CH; Monsieurs P; Lammens C; Ducher A; Vehreschild MJGT; Goossens H; de Gunzburg J; Bonten MJM; Malhotra-Kumar S;
Nat Commun; 2021 Apr; 12(1):2241. PubMed ID: 33854066
[TBL] [Abstract][Full Text] [Related]
22. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
[TBL] [Abstract][Full Text] [Related]
23. Clostridioides difficile and the Microbiota Early in Life.
Semon AK; Keenan O; Zackular JP
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S3-S7. PubMed ID: 34791400
[TBL] [Abstract][Full Text] [Related]
24. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
Tomkovich S; Stough JMA; Bishop L; Schloss PD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
[TBL] [Abstract][Full Text] [Related]
25. Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on
Chandra H; Sharma KK; Tuovinen OH; Sun X; Shukla P
Gut Microbes; 2021; 13(1):1979882. PubMed ID: 34724858
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection.
Herrera G; Vega L; Patarroyo MA; Ramírez JD; Muñoz M
Sci Rep; 2021 May; 11(1):10849. PubMed ID: 34035404
[TBL] [Abstract][Full Text] [Related]
27. Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization.
Abernathy-Close L; Dieterle MG; Vendrov KC; Bergin IL; Rao K; Young VB
Infect Immun; 2020 May; 88(6):. PubMed ID: 32284366
[No Abstract] [Full Text] [Related]
28. Acquisition site-based remodelling of Clostridium perfringens- and Clostridioides difficile-related gut microbiota.
Herrera G; Vega L; Camargo A; Patarroyo MA; Ramírez JD; Muñoz M
Comp Immunol Microbiol Infect Dis; 2023 Nov; 102():102074. PubMed ID: 37832162
[TBL] [Abstract][Full Text] [Related]
29. The microbial-derived bile acid lithocholate and its epimers inhibit
Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM
J Bacteriol; 2023 Sep; 205(9):e0018023. PubMed ID: 37695856
[No Abstract] [Full Text] [Related]
30. Infection With
Schmidt CJ; Wenndorf K; Ebbers M; Volzke J; Müller M; Strübing J; Kriebel K; Kneitz S; Kreikemeyer B; Müller-Hilke B
Front Immunol; 2020; 11():571049. PubMed ID: 33193352
[TBL] [Abstract][Full Text] [Related]
31. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
Schubert AM; Rogers MA; Ring C; Mogle J; Petrosino JP; Young VB; Aronoff DM; Schloss PD
mBio; 2014 May; 5(3):e01021-14. PubMed ID: 24803517
[TBL] [Abstract][Full Text] [Related]
32. Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.
Robinson JI; Weir WH; Crowley JR; Hink T; Reske KA; Kwon JH; Burnham CD; Dubberke ER; Mucha PJ; Henderson JP
J Clin Invest; 2019 Aug; 129(9):3792-3806. PubMed ID: 31403473
[TBL] [Abstract][Full Text] [Related]
33. Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant.
Leslie JL; Jenior ML; Vendrov KC; Standke AK; Barron MR; O'Brien TJ; Unverdorben L; Thaprawat P; Bergin IL; Schloss PD; Young VB
mBio; 2021 Mar; 12(2):. PubMed ID: 33785619
[No Abstract] [Full Text] [Related]
34. Shifts in the Gut Metabolome and
Fletcher JR; Erwin S; Lanzas C; Theriot CM
mSphere; 2018; 3(2):. PubMed ID: 29600278
[TBL] [Abstract][Full Text] [Related]
35. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.
Theriot CM; Young VB
Gut Microbes; 2014; 5(1):86-95. PubMed ID: 24335555
[TBL] [Abstract][Full Text] [Related]
36. Gut Microbiota Diversity of Preterm Neonates Is Associated With
Couturier J; Lepage P; Jolivet S; Delannoy J; Mesa V; Ancel PY; Rozé JC; Butel MJ; Barbut F; Aires J
Front Cell Infect Microbiol; 2022; 12():907323. PubMed ID: 35873148
[TBL] [Abstract][Full Text] [Related]
37. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of Colonization Resistance Against Clostridioides difficile.
Pike CM; Theriot CM
J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
[TBL] [Abstract][Full Text] [Related]
39. Capturing the environment of the Clostridioides difficile infection cycle.
Schnizlein MK; Young VB
Nat Rev Gastroenterol Hepatol; 2022 Aug; 19(8):508-520. PubMed ID: 35468953
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile and the microbiota.
Seekatz AM; Young VB
J Clin Invest; 2014 Oct; 124(10):4182-9. PubMed ID: 25036699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
